Hemophilia: Treatment for People Who Have Inhibitors
Hemophilia: Treatment for People Who Have InhibitorsSkip to the navigationTopic OverviewWhat are inhibitors?Some people who have
hemophilia A develop antibodies to the injected
clotting factor. The body thinks that
the replacement clotting factors don't belong in the body, so it creates
the antibodies, also called inhibitors, to get rid of them. Inhibitors may make it harder to treat bleeding episodes because the
body's natural defense system (immune system) interferes with the
function of replacement clotting factors. Some
people produce few inhibitors; others produce many. How can I be treated?If you have inhibitors, hemophilia treatment may require
specially engineered replacement clotting factors. Other treatment for clotting
factor inhibitors includes therapy to suppress the immune system
(immunosuppressive therapy). If you have a larger amount of inhibitors, you might be treated with: - Factor bypassing agents. These clotting factors are used
to skip the part of the clotting process that requires either clotting factor
VIII or IX. This treatment is unpredictable, and it is hard to determine the
correct dose. This treatment also slightly increases
your risk of having a heart attack or developing blood clots.
- A
regimen that allows the body to get used to the clotting factors so that they
won't produce as many or any inhibitors. This is done by giving large amounts
of clotting factors daily over an extended period of time.
During the first part of the treatment, you will get a factor bypassing agent
along with the regular clotting factors to make sure that any injury will heal.
After the body starts getting used to the clotting factors, the bypassing agent
is no longer needed.
If your body produces few inhibitors in reaction to clotting
factors,
you may be treated with clotting factor concentrate that is made in a lab (recombinant clotting factors). You might get large doses of the clotting factors, which can
overwhelm the inhibitors. ReferencesOther Works Consulted- Roberts HR, et al. (2010). Hemophilia A and hemophilia B. In K Kaushansky et al., eds., Williams Hematology, 8th ed., pp. 2009-2029. New York: McGraw-Hill.
CreditsByHealthwise Staff Primary Medical ReviewerE. Gregory Thompson, MD - Internal Medicine Adam Husney, MD - Family Medicine Martin J. Gabica, MD - Family Medicine Specialist Medical ReviewerBrian Leber, MDCM, FRCPC - Hematology Current as ofOctober 13, 2016 Current as of:
October 13, 2016 Last modified on: 8 September 2017
|
|
|
|
|
|